Endocare signs Asian cryoablation deals:
This article was originally published in Clinica
Executive Summary
Endocare has formed exclusive distribution agreements with Ensafe Industrial for Taiwan, and Inchcape Healthcare for Singapore, for Endocare's targeted cryoablation technology for liver cancer. Endocare, of Irvine, California, says the two companies will sell and service its technology in countries where the per capita incidence of liver cancer is significantly higher than the global average. Endocare is negotiating similar distribution agreements for China and Japan.